Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients (MICROGUT)

ANRS, Emerging Infectious Diseases

Status: Completed

Conditions: HIV-1 Infection

Treatments: Other: Physiopathology study

Study type: Observational

Funder types: Other

Identifiers

NCT02116374

2014-A00216-41 (Other Identifier)

ANRS EP55 MICROGUT

Details and patient eligibility

About

The bacterial diversity of HIV patients digestive microbiota seropositive is poorly understood, it remains to be defined.

Enrollment: 80 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient aged 18 or more.
• Patients with a confirmed diagnosis of HIV infection 1.
• Patient who signed an informed consent form.
• Patient affiliated or beneficiary of a social security system.

Exclusion criteria

• Patient known to be suffering from inflammatory bowel disease (Crohn's disease or ulcerative colitis).
• Patient HIV-2 or HIV-1/HIV-2 co-infected
• Patient having received immunotherapy
• Patient participating in another research.
• Pregnant women, parturient or lactating person under guardianship, or deprived of liberty by a judicial or administrative decision.

Trial design

80 participants in 1 patient group

HIV-1 patients

Treatment:

Other: Physiopathology study